COVID-19 Outbreak-Global Oncology Biosimilars Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Oncology Biosimilars are kind of Biosimilars. A biosimilar product is a biologic agent that is highly similar to an already-approved biological compound, known as the reference or originator product, and approved for use in the same indications as the reference product
The Oncology Biosimilars market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Oncology Biosimilars industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Oncology Biosimilars market can be split based on product types, major applications, and important countries as follows:
Key players in the global Oncology Biosimilars market covered in Chapter 12:
Teva Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd.
Sandoz International GmbH
Amgen Biosimilars
Samsung Bioepis Co. Ltd.
Celltrion Inc.
Pfizer, Inc.
Intas Pharmaceuticals Ltd.
In Chapter 4 and 14.1, on the basis of types, the Oncology Biosimilars market from 2015 to 2025 is primarily split into:
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
In Chapter 5 and 14.2, on the basis of applications, the Oncology Biosimilars market from 2015 to 2025 covers:
Retail pharmacies
Hospital pharmacies
Online pharmacies
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Oncology Biosimilars Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Oncology Biosimilars
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Oncology Biosimilars industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Oncology Biosimilars Market Size, 2015 - 2020
2.1.2 Global Oncology Biosimilars Market Size by Type, 2015 - 2020
2.1.3 Global Oncology Biosimilars Market Size by Application, 2015 - 2020
2.1.4 Global Oncology Biosimilars Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Oncology Biosimilars Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Oncology Biosimilars Analysis
3.2 Major Players of Oncology Biosimilars
3.3 Oncology Biosimilars Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Oncology Biosimilars
3.3.3 Labor Cost of Oncology Biosimilars
3.4 Market Distributors of Oncology Biosimilars
3.5 Major Downstream Buyers of Oncology Biosimilars Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Oncology Biosimilars Market, by Type
4.1 Global Oncology Biosimilars Value and Market Share by Type (2015-2020)
4.2 Global Oncology Biosimilars Production and Market Share by Type (2015-2020)
4.3 Global Oncology Biosimilars Value and Growth Rate by Type (2015-2020)
4.3.1 Global Oncology Biosimilars Value and Growth Rate of G-CSF
4.3.2 Global Oncology Biosimilars Value and Growth Rate of Hematopoietic Agents
4.3.3 Global Oncology Biosimilars Value and Growth Rate of Monoclonal Antibodies
4.4 Global Oncology Biosimilars Price Analysis by Type (2015-2020)
5 Oncology Biosimilars Market, by Application
5.1 Downstream Market Overview
5.2 Global Oncology Biosimilars Consumption and Market Share by Application (2015-2020)
5.3 Global Oncology Biosimilars Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Oncology Biosimilars Consumption and Growth Rate of Retail pharmacies (2015-2020)
5.3.2 Global Oncology Biosimilars Consumption and Growth Rate of Hospital pharmacies (2015-2020)
5.3.3 Global Oncology Biosimilars Consumption and Growth Rate of Online pharmacies (2015-2020)
6 Global Oncology Biosimilars Market Analysis by Regions
6.1 Global Oncology Biosimilars Sales, Revenue and Market Share by Regions
6.1.1 Global Oncology Biosimilars Sales by Regions (2015-2020)
6.1.2 Global Oncology Biosimilars Revenue by Regions (2015-2020)
6.2 North America Oncology Biosimilars Sales and Growth Rate (2015-2020)
6.3 Europe Oncology Biosimilars Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Oncology Biosimilars Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Oncology Biosimilars Sales and Growth Rate (2015-2020)
6.6 South America Oncology Biosimilars Sales and Growth Rate (2015-2020)
7 North America Oncology Biosimilars Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Oncology Biosimilars Sales, Revenue and Market Share by Countries
7.2.1 North America Oncology Biosimilars Sales by Countries (2015-2020)
7.2.2 North America Oncology Biosimilars Revenue by Countries (2015-2020)
7.3 United States Oncology Biosimilars Sales and Growth Rate (2015-2020)
7.4 Canada Oncology Biosimilars Sales and Growth Rate (2015-2020)
7.5 Mexico Oncology Biosimilars Sales and Growth Rate (2015-2020)
8 Europe Oncology Biosimilars Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Oncology Biosimilars Sales, Revenue and Market Share by Countries
8.2.1 Europe Oncology Biosimilars Sales by Countries (2015-2020)
8.2.2 Europe Oncology Biosimilars Revenue by Countries (2015-2020)
8.3 Germany Oncology Biosimilars Sales and Growth Rate (2015-2020)
8.4 UK Oncology Biosimilars Sales and Growth Rate (2015-2020)
8.5 France Oncology Biosimilars Sales and Growth Rate (2015-2020)
8.6 Italy Oncology Biosimilars Sales and Growth Rate (2015-2020)
8.7 Spain Oncology Biosimilars Sales and Growth Rate (2015-2020)
8.8 Russia Oncology Biosimilars Sales and Growth Rate (2015-2020)
9 Asia Pacific Oncology Biosimilars Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Oncology Biosimilars Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Oncology Biosimilars Sales by Countries (2015-2020)
9.2.2 Asia Pacific Oncology Biosimilars Revenue by Countries (2015-2020)
9.3 China Oncology Biosimilars Sales and Growth Rate (2015-2020)
9.4 Japan Oncology Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Korea Oncology Biosimilars Sales and Growth Rate (2015-2020)
9.6 India Oncology Biosimilars Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Oncology Biosimilars Sales and Growth Rate (2015-2020)
9.8 Australia Oncology Biosimilars Sales and Growth Rate (2015-2020)
10 Middle East and Africa Oncology Biosimilars Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Oncology Biosimilars Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Oncology Biosimilars Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Oncology Biosimilars Revenue by Countries (2015-2020)
10.3 Saudi Arabia Oncology Biosimilars Sales and Growth Rate (2015-2020)
10.4 UAE Oncology Biosimilars Sales and Growth Rate (2015-2020)
10.5 Egypt Oncology Biosimilars Sales and Growth Rate (2015-2020)
10.6 Nigeria Oncology Biosimilars Sales and Growth Rate (2015-2020)
10.7 South Africa Oncology Biosimilars Sales and Growth Rate (2015-2020)
11 South America Oncology Biosimilars Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Oncology Biosimilars Sales, Revenue and Market Share by Countries
11.2.1 South America Oncology Biosimilars Sales by Countries (2015-2020)
11.2.2 South America Oncology Biosimilars Revenue by Countries (2015-2020)
11.3 Brazil Oncology Biosimilars Sales and Growth Rate (2015-2020)
11.4 Argentina Oncology Biosimilars Sales and Growth Rate (2015-2020)
11.5 Columbia Oncology Biosimilars Sales and Growth Rate (2015-2020)
11.6 Chile Oncology Biosimilars Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Teva Pharmaceutical Industries Ltd
12.1.1 Teva Pharmaceutical Industries Ltd Basic Information
12.1.2 Oncology Biosimilars Product Introduction
12.1.3 Teva Pharmaceutical Industries Ltd Production, Value, Price, Gross Margin 2015-2020
12.2 Dr. Reddy's Laboratories Ltd.
12.2.1 Dr. Reddy's Laboratories Ltd. Basic Information
12.2.2 Oncology Biosimilars Product Introduction
12.2.3 Dr. Reddy's Laboratories Ltd. Production, Value, Price, Gross Margin 2015-2020
12.3 Sandoz International GmbH
12.3.1 Sandoz International GmbH Basic Information
12.3.2 Oncology Biosimilars Product Introduction
12.3.3 Sandoz International GmbH Production, Value, Price, Gross Margin 2015-2020
12.4 Amgen Biosimilars
12.4.1 Amgen Biosimilars Basic Information
12.4.2 Oncology Biosimilars Product Introduction
12.4.3 Amgen Biosimilars Production, Value, Price, Gross Margin 2015-2020
12.5 Samsung Bioepis Co. Ltd.
12.5.1 Samsung Bioepis Co. Ltd. Basic Information
12.5.2 Oncology Biosimilars Product Introduction
12.5.3 Samsung Bioepis Co. Ltd. Production, Value, Price, Gross Margin 2015-2020
12.6 Celltrion Inc.
12.6.1 Celltrion Inc. Basic Information
12.6.2 Oncology Biosimilars Product Introduction
12.6.3 Celltrion Inc. Production, Value, Price, Gross Margin 2015-2020
12.7 Pfizer, Inc.
12.7.1 Pfizer, Inc. Basic Information
12.7.2 Oncology Biosimilars Product Introduction
12.7.3 Pfizer, Inc. Production, Value, Price, Gross Margin 2015-2020
12.8 Intas Pharmaceuticals Ltd.
12.8.1 Intas Pharmaceuticals Ltd. Basic Information
12.8.2 Oncology Biosimilars Product Introduction
12.8.3 Intas Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Oncology Biosimilars Market Forecast
14.1 Global Oncology Biosimilars Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 G-CSF Market Value and Volume Forecast (2020-2025)
14.1.2 Hematopoietic Agents Market Value and Volume Forecast (2020-2025)
14.1.3 Monoclonal Antibodies Market Value and Volume Forecast (2020-2025)
14.2 Global Oncology Biosimilars Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Retail pharmacies Market Value and Volume Forecast (2020-2025)
14.2.2 Hospital pharmacies Market Value and Volume Forecast (2020-2025)
14.2.3 Online pharmacies Market Value and Volume Forecast (2020-2025)
14.3 Oncology Biosimilars Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Tables and Figures
List of Tables and Figures
Figure Product Picture of Oncology Biosimilars
Table Product Specification of Oncology Biosimilars
Table Oncology Biosimilars Key Market Segments
Table Key Players Oncology Biosimilars Covered
Figure Global Oncology Biosimilars Market Size, 2015 - 2025
Table Different Types of Oncology Biosimilars
Figure Global Oncology Biosimilars Value ($) Segment by Type from 2015-2020
Figure Global Oncology Biosimilars Market Share by Types in 2019
Table Different Applications of Oncology Biosimilars
Figure Global Oncology Biosimilars Value ($) Segment by Applications from 2015-2020
Figure Global Oncology Biosimilars Market Share by Applications in 2019
Figure Global Oncology Biosimilars Market Share by Regions in 2019
Figure North America Oncology Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure Europe Oncology Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Oncology Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Oncology Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure South America Oncology Biosimilars Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Oncology Biosimilars
Table Upstream Raw Material Suppliers of Oncology Biosimilars with Contact Information
Table Major Players Headquarters, and Service Area of Oncology Biosimilars
Figure Major Players Production Value Market Share of Oncology Biosimilars in 2019
Table Major Players Oncology Biosimilars Product Types in 2019
Figure Production Process of Oncology Biosimilars
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Channel Status of Oncology Biosimilars
Table Major Distributors of Oncology Biosimilars with Contact Information
Table Major Downstream Buyers of Oncology Biosimilars with Contact Information
Table Global Oncology Biosimilars Value ($) by Type (2015-2020)
Table Global Oncology Biosimilars Value Share by Type (2015-2020)
Figure Global Oncology Biosimilars Value Share by Type (2015-2020)
Table Global Oncology Biosimilars Production by Type (2015-2020)
Table Global Oncology Biosimilars Production Share by Type (2015-2020)
Figure Global Oncology Biosimilars Production Share by Type (2015-2020)
Figure Global Oncology Biosimilars Value ($) and Growth Rate of G-CSF (2015-2020)
Figure Global Oncology Biosimilars Value ($) and Growth Rate of Hematopoietic Agents (2015-2020)
Figure Global Oncology Biosimilars Value ($) and Growth Rate of Monoclonal Antibodies (2015-2020)
Figure Global Oncology Biosimilars Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Oncology Biosimilars Consumption by Application (2015-2020)
Table Global Oncology Biosimilars Consumption Market Share by Application (2015-2020)
Figure Global Oncology Biosimilars Consumption Market Share by Application (2015-2020)
Figure Global Oncology Biosimilars Consumption and Growth Rate of Retail pharmacies (2015-2020)
Figure Global Oncology Biosimilars Consumption and Growth Rate of Hospital pharmacies (2015-2020)
Figure Global Oncology Biosimilars Consumption and Growth Rate of Online pharmacies (2015-2020)
Figure Global Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Global Oncology Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Global Oncology Biosimilars Sales by Regions (2015-2020)
Table Global Oncology Biosimilars Sales Market Share by Regions (2015-2020)
Table Global Oncology Biosimilars Revenue (M USD) by Regions (2015-2020)
Table Global Oncology Biosimilars Revenue Market Share by Regions (2015-2020)
Table Global Oncology Biosimilars Revenue Market Share by Regions in 2015
Table Global Oncology Biosimilars Revenue Market Share by Regions in 2019
Figure North America Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure South America Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Oncology Biosimilars Revenue (M USD) and Growth (2015-2020)
Table North America Oncology Biosimilars Sales by Countries (2015-2020)
Table North America Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table North America Oncology Biosimilars Revenue (M USD) by Countries (2015-2020)
Table North America Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Figure United States Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Canada Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Mexico Oncology Biosimilars Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Oncology Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Europe Oncology Biosimilars Sales by Countries (2015-2020)
Table Europe Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table Europe Oncology Biosimilars Revenue (M USD) by Countries (2015-2020)
Table Europe Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Figure Germany Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure UK Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure France Oncology Biosimilars Sales and Growth (2015-2020)
Figure Italy Oncology Biosimilars Sales and Growth (2015-2020)
Figure Spain Oncology Biosimilars Sales and Growth (2015-2020)
Figure Russia Oncology Biosimilars Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Oncology Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Oncology Biosimilars Sales by Countries (2015-2020)
Table Asia Pacific Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table Asia Pacific Oncology Biosimilars Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Figure China Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Japan Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure South Korea Oncology Biosimilars Sales and Growth (2015-2020)
Figure India Oncology Biosimilars Sales and Growth (2015-2020)
Figure Southeast Asia Oncology Biosimilars Sales and Growth (2015-2020)
Figure Australia Oncology Biosimilars Sales and Growth (2015-2020)
Figure Middle East Oncology Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Middle East Oncology Biosimilars Sales by Countries (2015-2020)
Table Middle East and Africa Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Oncology Biosimilars Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure UAE Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Egypt Oncology Biosimilars Sales and Growth (2015-2020)
Figure Nigeria Oncology Biosimilars Sales and Growth (2015-2020)
Figure South Africa Oncology Biosimilars Sales and Growth (2015-2020)
Figure South America Oncology Biosimilars Revenue (M USD) and Growth (2015-2020)
Table South America Oncology Biosimilars Sales by Countries (2015-2020)
Table South America Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table South America Oncology Biosimilars Revenue (M USD) by Countries (2015-2020)
Table South America Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Figure Brazil Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Argentina Oncology Biosimilars Sales and Growth Rate (2015-2020)
Figure Columbia Oncology Biosimilars Sales and Growth (2015-2020)
Figure Chile Oncology Biosimilars Sales and Growth (2015-2020)
Figure Top 3 Market Share of Oncology Biosimilars Companies in 2019
Figure Top 6 Market Share of Oncology Biosimilars Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Product Introduction
Figure Teva Pharmaceutical Industries Ltd Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd Value ($) Market Share 2015-2020
Table Dr. Reddy's Laboratories Ltd. Profile
Table Dr. Reddy's Laboratories Ltd. Product Introduction
Figure Dr. Reddy's Laboratories Ltd. Production and Growth Rate
Figure Dr. Reddy's Laboratories Ltd. Value ($) Market Share 2015-2020
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Product Introduction
Figure Sandoz International GmbH Production and Growth Rate
Figure Sandoz International GmbH Value ($) Market Share 2015-2020
Table Amgen Biosimilars Profile
Table Amgen Biosimilars Product Introduction
Figure Amgen Biosimilars Production and Growth Rate
Figure Amgen Biosimilars Value ($) Market Share 2015-2020
Table Samsung Bioepis Co. Ltd. Profile
Table Samsung Bioepis Co. Ltd. Product Introduction
Figure Samsung Bioepis Co. Ltd. Production and Growth Rate
Figure Samsung Bioepis Co. Ltd. Value ($) Market Share 2015-2020
Table Celltrion Inc. Profile
Table Celltrion Inc. Product Introduction
Figure Celltrion Inc. Production and Growth Rate
Figure Celltrion Inc. Value ($) Market Share 2015-2020
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Product Introduction
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2015-2020
Table Intas Pharmaceuticals Ltd. Profile
Table Intas Pharmaceuticals Ltd. Product Introduction
Figure Intas Pharmaceuticals Ltd. Production and Growth Rate
Figure Intas Pharmaceuticals Ltd. Value ($) Market Share 2015-2020
Table Market Driving Factors of Oncology Biosimilars
Table Merger, Acquisition and New Investment
Table Global Oncology Biosimilars Market Value ($) Forecast, by Type
Table Global Oncology Biosimilars Market Volume Forecast, by Type
Figure Global Oncology Biosimilars Market Value ($) and Growth Rate Forecast of G-CSF (2020-2025)
Figure Global Oncology Biosimilars Market Volume ($) and Growth Rate Forecast of G-CSF (2020-2025)
Figure Global Oncology Biosimilars Market Value ($) and Growth Rate Forecast of Hematopoietic Agents (2020-2025)
Figure Global Oncology Biosimilars Market Volume ($) and Growth Rate Forecast of Hematopoietic Agents (2020-2025)
Figure Global Oncology Biosimilars Market Value ($) and Growth Rate Forecast of Monoclonal Antibodies (2020-2025)
Figure Global Oncology Biosimilars Market Volume ($) and Growth Rate Forecast of Monoclonal Antibodies (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Retail pharmacies (2020-2025)
Figure Market Volume and Growth Rate Forecast of Retail pharmacies (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospital pharmacies (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospital pharmacies (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Online pharmacies (2020-2025)
Figure Market Volume and Growth Rate Forecast of Online pharmacies (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter's Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Reason to Buy
- Current and future of Uncategorized Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Uncategorized Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets